Improving Drug Discovery Through Efficiency, Science and Expertise.
BioArdis is a preclinical biopharmaceutical development company. BioArdis focuses on best-in-class small molecule therapeutics, as well as cell-therapy, addressing the unmet medical needs of patients. The company’s virtual R&D drug development model allows for a high degree of flexibility in being able to respond rapidly to threats and opportunities, while remaining nimble and capital-efficient. The knowledgeable and agile team ensures that the potential therapies get into the clinic as soon as possible to meet patient demand.
BioArdis has the expertise of developing high-value preclinical drug candidates leveraging deep relationships with world-class scientists and business professionals with access to state-of-the-art facilities and capabilities.
BioArdis seeks to partner with companies to provide validated preclinical programs ready to advance into clinical development. Please contact BioArdis
if you would like to learn more about licensing opportunities.